オキシコドン医薬品の世界市場レポート 2025年

オキシコドン医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.0％で79億2,000万米ドルに成長します。予測期間の成長は、慢性疼痛の有病率の増加、外科手術件数の増加、製品パイプラインの継続的な開発が成長を後押しする見込みであること、ドラッグデリバリーシステムの進歩、慢性疼痛の発生率が高い世界の高齢化人口の増加などに起因しています。予測期間における主な動向としては、乱用抑止型製剤（ADFS）の需要増、新規デリバリーシステムの開発、併用療法の増加、製造技術の進歩などが挙げられます。

整形外科疾患のかなりの蔓延が、予測可能な将来においてオキシコドン医薬品市場の拡大を牽引する構えです。整形外科疾患には、骨、関節、靭帯、腱、筋肉に影響を及ぼすさまざまな筋骨格系の疾患が含まれ、多くの場合、疼痛、運動制限、機能障害をもたらします。整形外科疾患の増加には、高齢化、座りがちなライフスタイル、肥満、スポーツ関連傷害、職業上のリスクなどの要因があります。オキシコドン医薬品は、骨折、関節損傷、手術後の回復などに伴う急性および慢性の疼痛を緩和し、中枢神経系の疼痛受容体を調節することにより効果的な緩和を提供することで、整形外科疾患の管理において重要な役割を果たしています。例えば、米国を拠点とする研究機関であるInstitute for Health Metrics and Evaluationのデータによると、2020年から2050年にかけて、筋骨格系障害（整形外科疾患）の症例数は約115％（107～124％の範囲）の大幅な増加が予測されており、2050年までに有病者数は10億6,000万人に達すると推定されています。したがって、整形外科疾患の大きな負担がオキシコドン医薬品市場の成長軌道を支えています。

オキシコドン医薬品市場の主要企業は、注射や経鼻投与による薬物乱用を軽減するため、オキシコドン即時放出（IR）錠剤などの革新的な医薬品の開発に力を注いでいます。オキシコドン即時放出（IR）錠剤は、オピオイド鎮痛薬オキシコドンの製剤で、迅速な鎮痛を目的としています。例えば、米国を拠点とする製薬会社Protega Pharmaceuticals LLCは2022年7月、ロキシーボンド（オキシコドン）即時放出（IR）錠を米国で発売しました。RoxyBondは米国食品医薬品局（FDA）から、他の治療法では不十分な場合の重度疼痛管理用のオピオイド作動薬として承認を取得しています。RoxyBondは誤用や乱用を抑止する高度な技術を備えており、物理的あるいは化学的な改ざんが困難です。研究により、ロキシーボンドは従来のオキシコドン錠剤と比較して乱用の可能性が減少していることが示されており、これは薬物嗜好の評価や繰り返し服用したいという欲求が低いことからも明らかです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界オキシコドン医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のオキシコドン医薬品市場：成長率分析
• 世界のオキシコドン医薬品市場の実績：規模と成長, 2019-2024
• 世界のオキシコドン医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界オキシコドン医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオキシコドン医薬品市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 短時間作用型オキシコドン
• 長時間作用型オキシコドン
• 世界のオキシコドン医薬品市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• 注射
• 世界のオキシコドン医薬品市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経障害性疼痛
• 筋骨格系の痛み
• がんの痛み
• 術後の痛み
• その他の適応症
• 世界のオキシコドン医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のオキシコドン医薬品市場、短時間作用型オキシコドンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即放性オキシコドン錠
• オキシコドン経口液
• 世界のオキシコドン医薬品市場、長時間作用型オキシコドンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐放性オキシコドン錠
• オキシコドン徐放製剤

第7章 地域別・国別分析

• 世界のオキシコドン医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオキシコドン医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オキシコドン医薬品市場：競合情勢
• オキシコドン医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd
• Purdue Pharma L.P
• Endo International plc
• Amneal Pharmaceuticals LLC
• Mundipharma Pty Limited
• Alkermes plc
• Mallinckrodt Pharmaceuticals
• Alvogen Group Inc.
• Collegium Pharmaceutical Inc.
• Lannett Company Inc.
• Acorda Therapeutics Inc.
• Camurus AB
• Rhodes Pharmaceuticals L.P.
• KVK Tech Inc.
• Teikoku Pharma USA Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オキシコドン医薬品市場2029：新たな機会を提供する国
• オキシコドン医薬品市場2029：新たな機会を提供するセグメント
• オキシコドン医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oxycodone drug is a powerful opioid analgesic prescribed mainly to alleviate moderate to severe pain. Classified as an opioid agonist, it operates on precise receptors in the brain and spinal cord, modifying the perception of pain. When used properly and under medical supervision, oxycodone serves as an efficient method for pain management.

The primary classifications of oxycodone drugs encompass short-acting and long-acting formulations. Short-acting variants offer prompt pain relief with a brief duration of effect, typically employed for addressing acute pain instances such as post-surgery discomfort or injury-related pain. Oxycodone drugs are available in tablet, capsule, and injectable forms, prescribed for indications such as neuropathic pain, musculoskeletal pain, cancer-related pain, postoperative discomfort, among others. Their distribution spans across hospital pharmacies, retail outlets, and online platforms.

The oxycodone drugs market research report is one of a series of new reports from The Business Research Company that provides oxycodone drugs market statistics, including oxycodone drugs industry global market size, regional shares, competitors with a oxycodone drugs market share, detailed oxycodone drugs market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone drugs industry. This oxycodone drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oxycodone drugs market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to an aggressive marketing campaign for oxycontin, the drug was marketed for chronic non-malignant pain and cancer, the number of oxycontin prescriptions for non-cancer-related pain increased the demand for these drugs and after the second world war, synthetic opiates like oxycodone began to enter the market in greater numbers.

The oxycodone drugs market size is expected to see strong growth in the next few years. It will grow to $7.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the increasing prevalence of chronic pain, rising number of surgical procedures, ongoing development in the products pipeline is expected to boost the growth, advancements in drug delivery systems and a rising aging population worldwide experiencing a higher incidence of chronic pain. Major trends in the forecast period include increased demand for abuse-deterrent formulations (ADFS), the development of novel delivery systems, the growing use of combination therapies, and technological advancements in manufacturing.

The considerable prevalence of orthopedic disorders is poised to drive the expansion of the oxycodone drug market in the foreseeable future. Orthopedic disorders encompass various musculoskeletal conditions affecting bones, joints, ligaments, tendons, and muscles, often resulting in pain, restricted mobility, and functional impairments. The escalating occurrence of orthopedic disorders can be attributed to factors such as aging demographics, sedentary lifestyles, obesity, sports-related injuries, and occupational risks. Oxycodone drugs play a crucial role in managing orthopedic disorders by alleviating both acute and chronic pain associated with conditions such as fractures, joint injuries, or post-surgical recovery, offering effective relief through modulation of pain receptors in the central nervous system. For example, data from the Institute for Health Metrics and Evaluation, a US-based research institute, projects a substantial increase of approximately 115% (with a range of 107-124%) in musculoskeletal disorder cases (orthopedic disorders) from 2020 to 2050, reaching an estimated 1,060 million prevalent cases by 2050. Hence, the substantial burden of orthopedic disorders underpins the growth trajectory of the oxycodone drug market.

Major companies in the oxycodone drug market are concentrating their efforts on developing innovative medications, such as oxycodone immediate-release (IR) tablets, to mitigate drug abuse via injection and intranasal administration. Oxycodone immediate-release (IR) tablets are a formulation of the opioid analgesic oxycodone intended to deliver swift pain relief. For example, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical firm, introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. RoxyBond has obtained approval from the U.S. Food and Drug Administration (FDA) as an opioid agonist for severe pain management when other treatment options are insufficient. RoxyBond is equipped with advanced technology to deter misuse and abuse, making it challenging to tamper with physically or chemically. Studies have shown that RoxyBond demonstrates reduced potential for abuse compared to traditional oxycodone tablets, as evidenced by lower ratings for drug liking and desire for repeat consumption.

In February 2023, UNC Kenan-Flagler Business School, a US-based institution specializing in the Business of Health (CBOH), collaborated with Acadia Healthcare to create a flexible opioid settlement playbook. This collaboration seeks to outline the most efficient strategies for communities to deploy opioid settlement funds, particularly as communities nationwide, including those in North Carolina, are receiving substantial allocations to bolster opioid recovery initiatives from legal settlements involving opioid manufacturers and pharmacy chains. Acadia Healthcare Company, Inc. is a US-based organization offering behavioral healthcare services.

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

North America was the largest region in the oxycodone drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxycodone drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oxycodone drugs market consists of sales of hydrocodone, morphine, codeine, fentanyl, and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxycodone Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxycodone drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oxycodone drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oxycodone drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Short Acting Oxycodone; Long Acting Oxycodone
• 2) By Dosage Form: Tablets; Capsules; Injections
• 3) By Indication: Neuropathic Pain; Musculoskeletal Pain; Cancer Pain; Post Operative Pain; Other Indications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets; Oxycodone Oral Solution
• 2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets; Oxycodone Controlled-Release Formulations
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd; Daiichi Sankyo Company Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oxycodone Drugs Market Characteristics

3. Oxycodone Drugs Market Trends And Strategies

4. Oxycodone Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Oxycodone Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oxycodone Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oxycodone Drugs Market Growth Rate Analysis
• 5.4. Global Oxycodone Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oxycodone Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oxycodone Drugs Total Addressable Market (TAM)

6. Oxycodone Drugs Market Segmentation

• 6.1. Global Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short Acting Oxycodone
• Long Acting Oxycodone
• 6.2. Global Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injections
• 6.3. Global Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Post Operative Pain
• Other Indications
• 6.4. Global Oxycodone Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Oxycodone Drugs Market, Sub-Segmentation Of Short Acting Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immediate-Release Oxycodone Tablets
• Oxycodone Oral Solution
• 6.6. Global Oxycodone Drugs Market, Sub-Segmentation Of Long Acting Oxycodone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release Oxycodone Tablets
• Oxycodone Controlled-Release Formulations

7. Oxycodone Drugs Market Regional And Country Analysis

• 7.1. Global Oxycodone Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oxycodone Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oxycodone Drugs Market

• 8.1. Asia-Pacific Oxycodone Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oxycodone Drugs Market

• 9.1. China Oxycodone Drugs Market Overview
• 9.2. China Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oxycodone Drugs Market

• 10.1. India Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oxycodone Drugs Market

• 11.1. Japan Oxycodone Drugs Market Overview
• 11.2. Japan Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oxycodone Drugs Market

• 12.1. Australia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oxycodone Drugs Market

• 13.1. Indonesia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oxycodone Drugs Market

• 14.1. South Korea Oxycodone Drugs Market Overview
• 14.2. South Korea Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oxycodone Drugs Market

• 15.1. Western Europe Oxycodone Drugs Market Overview
• 15.2. Western Europe Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oxycodone Drugs Market

• 16.1. UK Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oxycodone Drugs Market

• 17.1. Germany Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oxycodone Drugs Market

• 18.1. France Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oxycodone Drugs Market

• 19.1. Italy Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oxycodone Drugs Market

• 20.1. Spain Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oxycodone Drugs Market

• 21.1. Eastern Europe Oxycodone Drugs Market Overview
• 21.2. Eastern Europe Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oxycodone Drugs Market

• 22.1. Russia Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oxycodone Drugs Market

• 23.1. North America Oxycodone Drugs Market Overview
• 23.2. North America Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oxycodone Drugs Market

• 24.1. USA Oxycodone Drugs Market Overview
• 24.2. USA Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oxycodone Drugs Market

• 25.1. Canada Oxycodone Drugs Market Overview
• 25.2. Canada Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oxycodone Drugs Market

• 26.1. South America Oxycodone Drugs Market Overview
• 26.2. South America Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oxycodone Drugs Market

• 27.1. Brazil Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oxycodone Drugs Market

• 28.1. Middle East Oxycodone Drugs Market Overview
• 28.2. Middle East Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oxycodone Drugs Market

• 29.1. Africa Oxycodone Drugs Market Overview
• 29.2. Africa Oxycodone Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oxycodone Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oxycodone Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oxycodone Drugs Market Competitive Landscape And Company Profiles

• 30.1. Oxycodone Drugs Market Competitive Landscape
• 30.2. Oxycodone Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Oxycodone Drugs Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd
• 31.2. Purdue Pharma L.P
• 31.3. Endo International plc
• 31.4. Amneal Pharmaceuticals LLC
• 31.5. Mundipharma Pty Limited
• 31.6. Alkermes plc
• 31.7. Mallinckrodt Pharmaceuticals
• 31.8. Alvogen Group Inc.
• 31.9. Collegium Pharmaceutical Inc.
• 31.10. Lannett Company Inc.
• 31.11. Acorda Therapeutics Inc.
• 31.12. Camurus AB
• 31.13. Rhodes Pharmaceuticals L.P.
• 31.14. KVK Tech Inc.
• 31.15. Teikoku Pharma USA Inc.

32. Global Oxycodone Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxycodone Drugs Market

34. Recent Developments In The Oxycodone Drugs Market

35. Oxycodone Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Oxycodone Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oxycodone Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oxycodone Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer